Skip to main content

Table 2 Laboratory data for the patient

From: Chronic calcium pyrophosphate crystal inflammatory arthritis induced by extreme hypomagnesemia in short bowel syndrome

Parameter

Before treatment

6 months after treatment

Hemoglobin (12 – 16 g/dl)

11.8

13.1

Leucocytes (4 – 10000/μl)

8600

7100

Thrombocytes (140 – 400000 μl)

354000

295000

ESR

7/9

4/6

CRP mg/l (<5)

0.4

1.1

Proteins g/l (66–83)

58.3

66.1

Albumin g/l (35–55)

41.1

39.4

Sodium mmol/l (135–145)

138

142

Potassium mmol/l (3,6-4,8)

3.4

4.1

Magnesium, mmol/l (0.7–1.1)

0.2

0.6

Calcium, mmol/l (2.1–2.7)

1.7

2.2

Phosporus mg/dl (2.5-4.5)

3.6

3.5

Transferrin saturation,% (16-45%)

37.5

36.4

Uric acid mg/dl (3.4-7)

5.8

5.8

Serum creatinine mg/dl (0.84-1.25)

1.1

1.06

Urea mg/dl (17–43)

51

58

Zinc, μg/dl (72–175)

64

89

Triglycerides mg/dl (<200)

312

171

Cholesterol mg/dl (<200)

143

147

25OH vitamin D, ng/ml (30–70)

12

38

Vitamin B12 (200 – 1100 pg/ml)

151

241

Parathormone pg/ml (10–65)

11.3

15

  1. Laboratory data for the patient with SBS, extreme hypomagnesemia and calcium pyrophosphate crystal inflammatory arthritis (chondrocalcinosis) at the time of diagnosis and 6 months after intense interdisciplinary treatment.